Skip to main content

Peer Review reports

From: The expression landscape of JAK1 and its potential as a biomarker for prognosis and immune infiltrates in NSCLC

Original Submission
24 Mar 2021 Submitted Original manuscript
26 Apr 2021 Reviewed Reviewer Report
8 May 2021 Reviewed Reviewer Report - alessandro Russo
17 Jun 2021 Author responded Author comments - Weihua Lu
Resubmission - Version 2
17 Jun 2021 Submitted Manuscript version 2
15 Jul 2021 Author responded Author comments - Weihua Lu
Resubmission - Version 3
15 Jul 2021 Submitted Manuscript version 3
Publishing
17 Sep 2021 Editorially accepted
29 Sep 2021 Article published 10.1186/s12859-021-04379-y

You can find further information about peer review here.

Back to article page